Cutera (CUTR) Releases Earnings Results, Beats Estimates By $0.08 EPS

Cutera (NASDAQ:CUTR) released its quarterly earnings data on Tuesday. The medical device company reported $0.11 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.03 by $0.08, Briefing.com reports. Cutera had a net margin of 11.16% and a negative return on equity of 0.50%. The firm had revenue of $40.60 million for the quarter, compared to the consensus estimate of $40.03 million. During the same quarter in the prior year, the company posted $0.42 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. Cutera updated its FY 2018 guidance to $0.40-0.50 EPS and its FY18 guidance to $0.40-0.50 EPS.

NASDAQ CUTR opened at $20.71 on Thursday. Cutera has a 1 year low of $19.11 and a 1 year high of $56.05. The firm has a market capitalization of $294.03 million, a PE ratio of 26.90 and a beta of 0.83.

In other news, insider James A. Reinstein bought 1,000 shares of Cutera stock in a transaction dated Wednesday, August 29th. The stock was purchased at an average price of $32.02 per share, for a total transaction of $32,020.00. Following the purchase, the insider now directly owns 139,907 shares in the company, valued at approximately $4,479,822.14. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.80% of the company’s stock.

Several research analysts have weighed in on the stock. BidaskClub downgraded shares of Cutera from a “strong-buy” rating to a “buy” rating in a report on Friday, July 27th. Stifel Nicolaus lowered their price objective on shares of Cutera from $55.00 to $45.00 and set a “hold” rating on the stock in a report on Wednesday, August 8th. Zacks Investment Research downgraded shares of Cutera from a “hold” rating to a “sell” rating in a report on Monday, August 13th. ValuEngine downgraded shares of Cutera from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 8th. Finally, Stephens lowered their price objective on shares of Cutera from $40.00 to $24.94 and set a “sell” rating on the stock in a report on Friday, October 5th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $39.24.

COPYRIGHT VIOLATION WARNING: “Cutera (CUTR) Releases Earnings Results, Beats Estimates By $0.08 EPS” was first published by WKRB News and is the sole property of of WKRB News. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.wkrb13.com/2018/11/08/cutera-cutr-releases-earnings-results-beats-estimates-by-0-08-eps.html.

Cutera Company Profile

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Recommended Story: Analyst Ratings

Earnings History for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply